News

Celsius Holdings Stock Update: Challenges and Strategies Ahead

Celsius Holdings Stock Update: Challenges and Strategies Ahead

Celsius Holdings' Current Stock Performance

Celsius Holdings, Inc. (NASDAQ: CELH) has seen its shares decline slightly recently. According to a recent analysis by Bank of America, the company’s projected sales for the third quarter of its 2024 fiscal year have been revised to $289 million. This adjustment is a direct response to concerns regarding inventory management.

The Challenges of Excess Inventory

Bank of America pointed out that the lowered sales figures stem from what they describe as ‘too much inventory’ on Celsius's books, predicting a significant impact of approximately $110 million on overall sales. This issue arose amid slower than expected growth, necessitating strategic steps from Celsius to mitigate its inventory pile-up.

Financial Projections Adjusted

Alongside the sales estimate adjustments, Bank of America has also revised its financial projections for Celsius. The firm's estimate for Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) has been cut from $45 million to $25.5 million. Furthermore, the estimated earnings per share (EPS) decreased from 12 cents to 7 cents due to these inventory challenges.

Marketing and Sales Strategy Outlook

In light of these challenges, Bank of America has also raised its estimates for Celsius's selling and marketing expenses to $90 million. The bank anticipates that Celsius will continue aggressively spending on advertising to stimulate further demand for its beverage products and maintain market relevance.

Participating in the Celsius Stock Market

If you're considering engaging in the market for Celsius Holdings stock (NASDAQ: CELH), it's essential to know how to purchase shares. The most common method is through a brokerage account, where various platforms provide the option to acquire shares, including fractional shares. This flexibility allows investors with limited budgets to partake in stock ownership without buying entire shares, which can be prohibitively expensive for high-value stocks.

Celsius Stock Current Trading Price

As of the latest update, Celsius Holdings stock is currently valued at $34.48, reflecting a drop of 0.99% at the time of publication. Understanding the market fluctuations can greatly influence investment strategies moving forward.

The Short Selling Process Explained

For those more adventurous investors looking to take a stance against the stock, short selling can be a viable approach. This requires access to an options trading platform, where you can sell borrowed shares of stock in anticipation of a price decline. Alternatively, if your brokerage allows it, you could engage in options trading by purchasing a put option or selling a call option, which can lead to profitable outcomes even when share prices dip.

Conclusion: What Lies Ahead for Celsius Holdings?

Celsius Holdings, Inc. is facing significant challenges, particularly regarding inventory management and growth projections. However, with its ongoing commitment to marketing and product demand, along with strategic financial adjustments, the company aims to regain a favorable market position. Investors should remain alert to future developments that could impact share performance.

Frequently Asked Questions

What challenges is Celsius Holdings currently facing?

Celsius is currently dealing with excess inventory issues, leading to lowered sales estimates and adjusted financial projections.

What are the new sales projections for Celsius Holdings?

Bank of America has revised Celsius's projected sales for Q3 2024 to $289 million due to inventory concerns.

How has Celsius's EBITDA and EPS been affected?

The EBITDA estimate has been cut to $25.5 million and EPS adjusted to 7 cents as a result of inventory management issues.

What strategies is Celsius employing to increase demand?

The company is increasing its marketing expenses to $90 million to boost product visibility and stimulate demand.

How can investors participate in Celsius Holdings?

Investors can purchase Celsius shares through various brokerage accounts, with options for buying fractional shares available for easier access.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 46

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading
Medicare Limits and Long-Term Care Planning Tips

Updated Category News Views 16

Grappling with Medicare's Gaps Most folks hear Medicare and feel a sigh of relief—thinking it's a catch-all net for healthcare in your golden years. But hold on, when it comes to long-term care, Medicare's got more holes than Swiss cheese. Cindy Couyoumjian from Cinergy Financial lays it out pretty clear: Medicare doesn't cover what it calls 'custodial care'—you know,...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 3

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 44

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Shanghai and Hamburg Celebrate 40 Years of Collaboration

Updated Category News Views 6

Strengthening the Bond: A Four-Decade Journey With fireworks of diplomacy and cooperation lighting up, Shanghai and Hamburg marked the 40th anniversary of their friendship with an ambition to deepen and broaden ties. These cities, separated by continents but united by their maritime spirit, decided to toast not just the past but also the future. This isn't just some fancy...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
Dimora Medical Boosts Advanced Wound Care at HS Conference

Updated Category News Views 52

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Continue Reading
Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Updated Category News Views 25

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Continue Reading
Northern Virginia's Housing Inventory Surges Despite Market Pressures

Updated Category News Views 4

Unexpected Surge in Northern Virginia's Inventory Walking around Fairfax these days, you might feel like you're in a time warp, especially if you're tracking the housing market. See, while the rest of the country's housing market groans under sluggish sales and creeping prices, Northern Virginia's doing a dance of its own. Inventory's ballooning faster than a parade...

Continue Reading
Hexagon Composites to Release Q3 2026 Results Soon

Updated Category News Views 18

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovations at Lifecore Biomedical: Industry Conferences Ahead

Updated Category News Views 156

Exciting Events for Lifecore Biomedical Lifecore Biomedical, Inc. (NASDAQ: LFCR), a prominent contract development and manufacturing organization (CDMO), is gearing up to participate in three significant industry events. These conferences represent a vital opportunity for Lifecore to showcase its advanced capabilities and connect with potential partners in the...

Continue Reading
Important Update for Biohaven Ltd. (BHVN) Investors – Legal Action Notice

Updated Category News Views 147

Class Action Lawsuit Filed Against Biohaven Ltd. Recent developments indicate that a class action lawsuit has been initiated against Biohaven Ltd. (BHVN), raising serious concerns for shareholders. Allegations suggest that the company, along with certain defendants, made misleading statements or outright failed to disclose critical information about its operations and...

Continue Reading
ASM International N.V. Releases Comprehensive Annual Report 2024

Updated Category News Views 742

ASM International N.V. Unveils Annual Report for 2024 ASM International N.V. (Euronext Amsterdam: ASM) is excited to announce the publication of its Annual Report for 2024. This comprehensive document is readily accessible in the ESEF reporting package as well as a downloadable PDF on the company’s official online platform. Understanding the Annual Report The Annual...

Continue Reading
Transforming B2B Sales: Embracing Change for Success

Updated Category News Views 252

Transforming B2B Sales Strategies for 2025 In a world where business-to-business (B2B) sales strategies are rapidly evolving, Abstrakt is at the forefront of this transformation. The company’s President, Eric Watkins, has been vocal about the diminishing returns of traditional cold calling. The Decline of Cold Calling Watkins highlights that cold calling, long seen as a...

Continue Reading
Projected Growth of the Sodium Chlorite Market through 2032

Updated Category News Views 173

Understanding the Future of the Sodium Chlorite Market Sodium chlorite is set to undergo significant growth, with its market projected to rise from USD 258.76 million in 2023 to an impressive USD 415.61 million by 2032. This growth is not only a reflection of increasing industrial applications but also an acknowledgment of its essential role in water treatment and...

Continue Reading